Paula Jimenez Fonseca, Coordinator of the TRASGU study, nomogram, stage IV neuroendocrine tumors treated with somatostatin analogs in the GETNE Group, shared an article that her and her collogues co-authored in nature portfolio on X:
“Thank you SEOM for making our AGAMENON cure-model paper open access and all investigators.
In resected M0 esophageal adenocarcinoma, cure models show:
FLOT not only improves prognosis but also increases the cure fraction, especially in higher-risk patients.”
Quoting Biblioteca HUCA on X:
“PubMed: Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis.”
Title: Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis
Authors: Lucía Mateos, Paula Jiménez-Fonseca, Javier Gallego, Arturo Lecumberri, Ana Custodio, Eva Martínez de Castro, Raquel Hernández San Gil, Ana Fernández Montes, María Luisa Limón, Rosario Vidal-Tocino, Juana María Cano, Javier López Robles, Mireia Gil, Daniel Acosta Eyzaguirre, Gema Marín Zafra, Antonio José Mérida-García, Alejandro Francisco Fernández, Paula Ribera Fernández, Cinta Hierro, María Carmen Riesco, Montse García Araque, Maribel Ruiz Martín, Paola Pimentel, Laura Visa, Paula Cerdá, Mónica Granja, Ana Belén Rupérez Blanco, Lourdes Gutiérrez, Alberto Carmona-Bayonas
Read more posts about Esophageal Cancer on OncoDaily.